National Health Investors Stock Market Value
| NHI Stock | USD 76.65 0.26 0.34% |
| Symbol | National |
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
National Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to National Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of National Health.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in National Health on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding National Health Investors or generate 0.0% return on investment in National Health over 30 days. National Health is related to or competes with Omega Healthcare, Ventas, and Community Healthcare. is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of nee... More
National Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure National Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess National Health Investors upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 6.32 | |||
| Value At Risk | (2.29) | |||
| Potential Upside | 1.96 |
National Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as National Health's standard deviation. In reality, there are many statistical measures that can use National Health historical prices to predict the future National Health's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.27) |
National Health Investors Backtested Returns
National Health Investors has Sharpe Ratio of -0.028, which conveys that the firm had a -0.028% return per unit of risk over the last 3 months. National Health exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify National Health's Standard Deviation of 1.33, mean deviation of 1.05, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, National Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding National Health is expected to be smaller as well. At this point, National Health Investors has a negative expected return of -0.0374%. Please make sure to verify National Health's kurtosis, as well as the relationship between the day median price and relative strength index , to decide if National Health Investors performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.27 |
Weak reverse predictability
National Health Investors has weak reverse predictability. Overlapping area represents the amount of predictability between National Health time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of National Health Investors price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current National Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.27 | |
| Spearman Rank Test | -0.9 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
National Health Investors lagged returns against current returns
Autocorrelation, which is National Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting National Health's stock expected returns. We can calculate the autocorrelation of National Health returns to help us make a trade decision. For example, suppose you find that National Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
National Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If National Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if National Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in National Health stock over time.
Current vs Lagged Prices |
| Timeline |
National Health Lagged Returns
When evaluating National Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of National Health stock have on its future price. National Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, National Health autocorrelation shows the relationship between National Health stock current value and its past values and can show if there is a momentum factor associated with investing in National Health Investors.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out National Health Correlation, National Health Volatility and National Health Alpha and Beta module to complement your research on National Health. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
National Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.